Generation of blastoids from human parthenogenetic stem cells

Ke Zhong , Yu-Xin Luo , Dan Li , Zhe-Ying Min , Yong Fan , Yang Yu

Life Medicine ›› 2023, Vol. 2 ›› Issue (1) : 8

PDF (1928KB)
Life Medicine ›› 2023, Vol. 2 ›› Issue (1) : 8 DOI: 10.1093/lifemedi/lnad006
Article
Article

Generation of blastoids from human parthenogenetic stem cells

Author information +
History +
PDF (1928KB)

Abstract

Parthenogenetic embryos derive their genomes entirely from the maternal genome and lack paternal imprint patterns. Many achievements have been made in the study of genomic imprinting using human parthenogenetic embryonic stem cells (hPg-ESCs). However, due to developmental defects and ethical limits, a comprehensive understanding of parthenogenetic embryonic development is still lacking. Here, we generated parthenogenetic blastoids (hPg-EPSCs blastoids) from hPg-ESC-derived extended pluripotent stem cells (hPg-EPSCs) using our previously published two-step induction protocol. Morphology, specific marker expression and single-cell transcriptome analysis showed that hPg-EPSCs blastoids contain crucial cell lineages similar to blastoids (hBp-EPSCs blastoids) generated from human biparental EPSCs (hBp-EPSCs). Single-cell RNA-seq compared the expression of genes related to imprinting and X chromosome inactivation in hPg-EPSCs blastoids and hBp-EPSCs blastoids. In conclusion, we generated parthenogenetic blastoids, which will potentially promote the study of genomic imprinting in embryonic development and uncover the influence of parental origin bias on human development and pathological mechanisms.

Keywords

human parthenogenetic ESCs / blastoids / hEPSCs / imprinted genes / X chromosome

Cite this article

Download citation ▾
Ke Zhong, Yu-Xin Luo, Dan Li, Zhe-Ying Min, Yong Fan, Yang Yu. Generation of blastoids from human parthenogenetic stem cells. Life Medicine, 2023, 2(1): 8 DOI:10.1093/lifemedi/lnad006

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Brevini TA, Gandolfi F. Parthenotes as a source of embryonic stem cells. Cell Prolif 2008;41:20–30.

[2]

Surani MA, Barton SC, Norris ML. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis, Nature 1984;308:548–50.

[3]

Linder D, McCaw BK, Hecht F. Parthenogenic origin of benign ovarian teratomas. N Engl J Med 1975;292:63–6.

[4]

Kim K, Lerou P, Yabuuchi A, et al. Histocompatible embryonic stem cells by parthenogenesis. Science 2007;315:482–6.

[5]

Mai Q, Yu Y, Li T, et al. Derivation of human embryonic stem cell lines from parthenogenetic blastocysts. Cell Res 2007;17:1008–19.

[6]

Revazova ES, Turovets NA, Kochetkova OD, et al. Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 2007;9:432–49.

[7]

Yu Y, Gao Q, Zhao H-C, et al. Ascorbic acid improves pluripotency of human parthenogenetic embryonic stem cells through modifying imprinted gene expression in the Dlk1-Dio3 region. Stem Cell Res Ther 2015;6:69.

[8]

Thomson JA, Solter D. The developmental fate of androgenetic, parthenogenetic, and gynogenetic cells in chimeric gastrulating mouse embryos. Genes Dev 1988;2:1344–51.

[9]

Barton SC, Surani MA, Norris ML. Role of paternal and maternal genomes in mouse development. Nature 1984;311:374–6.

[10]

Tucci V, Isles AR, Kelsey G, et al; Erice Imprinting Group. Genomic imprinting and physiological processes in mammals. Cell 2019;176:952–65.

[11]

Sagi, I, De Pinho Joao C, Zuccaro MV, et al. Distinct imprinting signatures and biased differentiation of human androgenetic and parthenogenetic embryonic stem cells, Cell Stem Cell, 2019;25:419–432.e9.

[12]

Fan Y, Min Z, Alsolami S, et al. Generation of human blastocyst-like structures from pluripotent stem cells. Cell Discov 2021;7:81.

[13]

Kagawa H, Javali A, Khoei HH, et al. Human blastoids model blastocyst development and implantation. Nature 2022;601:600–5.

[14]

Liu XD et al. Modelling human blastocysts by reprogramming fibroblasts into iBlastoids. Nature 2021;591:627.

[15]

Sozen B, Jorgensen V, Weatherbee BAT, et al. Reconstructing aspects of human embryogenesis with pluripotent stem cells. Nat Commun 2021;12:5550.

[16]

Yanagida, A, Spindlow D, Nichols J, et al. Naive stem cell blastocyst model captures human embryo lineage segregation, Cell Stem Cell 2021;28:1016–1022.e4.

[17]

Yu L, Wei Y, Duan J, et al. Blastocyst-like structures generated from human pluripotent stem cells. Nature 2021;591:620–6.

[18]

Li T, Vu TH, Lee K-O, et al. An imprinted PEG1/MEST antisense expressed predominantly in human testis and in mature spermatozoa. J Biol Chem 2002;277:13518–27.

[19]

Io, S, Kabata M, Iemura Y, et al. Capturing human trophoblast development with naive pluripotent stem cells in vitro, Cell Stem Cell 2021;28:1023–39.e13.

[20]

Qi Q, Ding C, Hong P, et al. X chromosome inactivation in human parthenogenetic embryonic stem cells following prolonged passaging. Int J Mol Med 2015;35:569–78.

[21]

Moreira de Mello JC, Fernandes GR, Vibranovski MD, et al. Early X chromosome inactivation during human preimplantation development revealed by single-cell RNA-sequencing. Sci Rep 2017;7:10794.

[22]

Patrat C, Ouimette JF, Rougeulle C. X chromosome inactivation in human development, Development 2020;147:dev183095.

[23]

Sun S, Del Rosario BC, Szanto A, et al. Jpx RNA activates Xist by evicting CTCF. Cell 2013;153:1537–51.

[24]

Tian, D, Sun, S, Lee, JT. The long noncoding RNA, Jpx, is a molecular switch for X chromosome inactivation. Cell 2010;143:390–403.

[25]

Furlan G, Gutierrez Hernandez N, Huret C, et al. The ftx noncoding locus controls X chromosome inactivation independently of Its RNA products. Mol Cell 2018;70:462–472.e8.

[26]

Nora EP, Lajoie BR, Schulz EG, et al. Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nature 2012;485:381–5.

[27]

Rosspopoff O, Huret C, Collier AJ, et al. Mechanistic diversification of XIST regulatory network in mammals. bioRxiv 2019;689430.

[28]

Pastor WA, Chen D, Liu W, et al. Naive human pluripotent cells feature a methylation landscape devoid of blastocyst or germline memory. Cell Stem Cell 2016;18:323–9.

[29]

Pereira G, Doria S. X-chromosome inactivation: implications in human disease. J Genet 2021;100:63.

[30]

Okamoto I, Patrat C, Thépot D, et al. Eutherian mammals use diverse strategies to initiate X-chromosome inactivation during development. Nature 2011;472:370–4.

[31]

Petropoulos S, Edsgärd D, Reinius B, et al. Single-cell RNA-seq reveals lineage and X chromosome dynamics in human preimplantation embryos. Cell 2016;167:285.

[32]

Vallot C, Patrat C, Collier AJ, et al. XACT Noncoding RNA competes with XIST in the control of X chromosome activity during human early development. Cell Stem Cell 2017;20:102–11.

[33]

Zhou Q, Wang T, Leng L, et al. Single-cell RNA-seq reveals distinct dynamic behavior of sex chromosomes during early human embryogenesis. Mol Reprod Dev 2019;86:871–82.

[34]

Skakkebaek A, Bojesen A, Kristensen MK, et al. Neuropsychology and brain morphology in Klinefelter syndrome - the impact of genetics. Andrology 2014;2:632–40.

[35]

Okamoto I, Otte AP, Allis CD, et al. Epigenetic dynamics of imprinted X inactivation during early mouse development. Science 2004;303:644–9.

[36]

Moreira de Mello JC, de Araújo ESS, Stabellini R, et al. Random X inactivation and extensive mosaicism in human placenta revealed by analysis of allele-specific gene expression along the X chromosome. PLoS One 2010;5:e10947.

[37]

Hamada H, Okae H, Toh H, et al. Allele-specific methylome and transcriptome analysis reveals widespread imprinting in the human placenta. Am J Hum Genet 2016;99:1045–58.

RIGHTS & PERMISSIONS

The Author(s) 2023. Published by Oxford University Press on behalf of Higher Education Press.

AI Summary AI Mindmap
PDF (1928KB)

Supplementary files

MDC-0008-23006-KZ_suppl_1

695

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/